These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 36138807)
1. Drug Efflux Pump Inhibitors: A Promising Approach to Counter Multidrug Resistance in Gram-Negative Pathogens by Targeting AcrB Protein from AcrAB-TolC Multidrug Efflux Pump from Alenazy R Biology (Basel); 2022 Sep; 11(9):. PubMed ID: 36138807 [TBL] [Abstract][Full Text] [Related]
2. Structures and Efflux Mechanisms of the AcrAB-TolC Pump. Yu Z; Shi X; Wang Z Subcell Biochem; 2024; 104():1-16. PubMed ID: 38963480 [TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump. Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV mBio; 2020 Jun; 11(3):. PubMed ID: 32487753 [TBL] [Abstract][Full Text] [Related]
5. The 2019 Garrod Lecture: MDR efflux in Gram-negative bacteria-how understanding resistance led to a new tool for drug discovery. Piddock LJV J Antimicrob Chemother; 2019 Nov; 74(11):3128-3134. PubMed ID: 31626705 [TBL] [Abstract][Full Text] [Related]
6. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576 [TBL] [Abstract][Full Text] [Related]
7. Sodium Malonate Inhibits the AcrAB-TolC Multidrug Efflux Pump of Cauilan A; Ruiz C Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558743 [TBL] [Abstract][Full Text] [Related]
8. Contribution of AcrAB-TolC to multidrug resistance in an Escherichia coli sequence type 131 isolate. Schuster S; Vavra M; Schweigger TM; Rossen JWA; Matsumura Y; Kern WV Int J Antimicrob Agents; 2017 Sep; 50(3):477-481. PubMed ID: 28689875 [TBL] [Abstract][Full Text] [Related]
9. Characterization of substituted piperazines able to reverse MDR in Escherichia coli strains overexpressing resistance-nodulation-cell division (RND) efflux pumps. Casalone E; Vignolini T; Braconi L; Gardini L; Capitanio M; Pavone FS; Giovannelli L; Dei S; Teodori E J Antimicrob Chemother; 2022 Feb; 77(2):413-424. PubMed ID: 34747445 [TBL] [Abstract][Full Text] [Related]
10. Extreme Acid Modulates Fitness Trade-Offs of Multidrug Efflux Pumps MdtEF-TolC and AcrAB-TolC in Escherichia coli K-12. Schaffner SH; Lee AV; Pham MTN; Kassaye BB; Li H; Tallada S; Lis C; Lang M; Liu Y; Ahmed N; Galbraith LG; Moore JP; Bischof KM; Menke CC; Slonczewski JL Appl Environ Microbiol; 2021 Jul; 87(16):e0072421. PubMed ID: 34085861 [TBL] [Abstract][Full Text] [Related]
11. Genetic Variability of the AcrAB-TolC Multidrug Efflux Pump Underlies SkQ1 Resistance in Gram-Negative Bacteria. Nazarov PA; Kotova EA; Skulachev VP; Antonenko YN Acta Naturae; 2019; 11(4):93-98. PubMed ID: 31993240 [TBL] [Abstract][Full Text] [Related]
12. Lack of AcrB Efflux Function Confers Loss of Virulence on Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV mBio; 2017 Jul; 8(4):. PubMed ID: 28720734 [TBL] [Abstract][Full Text] [Related]
13. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria]. Hasdemir U Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720 [TBL] [Abstract][Full Text] [Related]
14. Identification of Chowdhury N; Suhani S; Purkaystha A; Begum MK; Raihan T; Alam MJ; Islam K; Azad AK Microbiol Insights; 2019; 12():1178636119889629. PubMed ID: 31839709 [TBL] [Abstract][Full Text] [Related]
15. Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli. Wan X; Li Q; Olsen RH; Meng H; Zhang Z; Wang J; Zheng H; Li L; Shi L J Antimicrob Chemother; 2022 Jul; 77(8):2158-2166. PubMed ID: 35642356 [TBL] [Abstract][Full Text] [Related]
16. Fitness trade-offs of multidrug efflux pumps in Liu Y; Van Horn AM; Pham MTN; Dinh BNN; Chen R; Raphael SDR; Paulino A; Thaker K; Somadder A; Frost DJ; Menke CC; Slimak ZC; Slonczewski JL Appl Environ Microbiol; 2024 Feb; 90(2):e0209623. PubMed ID: 38289137 [TBL] [Abstract][Full Text] [Related]
17. Mapping the Role of AcrAB-TolC Efflux Pumps in the Evolution of Antibiotic Resistance Reveals Near-MIC Treatments Facilitate Resistance Acquisition. Langevin AM; El Meouche I; Dunlop MJ mSphere; 2020 Dec; 5(6):. PubMed ID: 33328350 [TBL] [Abstract][Full Text] [Related]
18. RND efflux pumps: structural information translated into function and inhibition mechanisms. Ruggerone P; Murakami S; Pos KM; Vargiu AV Curr Top Med Chem; 2013; 13(24):3079-100. PubMed ID: 24200360 [TBL] [Abstract][Full Text] [Related]
19. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Li XZ; Plésiat P; Nikaido H Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514 [TBL] [Abstract][Full Text] [Related]